Abstract LB167: A powerful discovery platform for the generation of high affinity and specificity TCR-like antibodies for immunotherapies in solid tumor

Authors: Stephanie Jungmichel, Fabian Scheifele, Anna Sobieraj, Philip Knobel, Philipp Richle, Hannes Merten, Thomas Schleier, Melissa Vrohlings, Christian Leisner, Leonardo Borras

Published: 2021-07-01

DOI: 10.1158/1538-7445.am2021-lb167

Source: Full article